3QQ-43573-90814
3 vaccinations
8 coded responses
24 check-ins
8 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 088 / NJ
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-22
Survey response — day 0, dose 1MedDRA: Office visit, Pre-existing disease, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Mild Asthma- due to Daily maintenance medications · Healthcare visit (other): Office visit with allergy/ asthma specialistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-22
Report sent to call center — day 0, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2020-12-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, HeadacheAdult check-in
- 2020-12-25
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-04
- 2021-01-05
- 2021-01-07
-
2021-01-07
Call successfulDoes not wish to fill out VAERS report
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-12
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Fever · Chills, HeadacheAdult check-in
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Injection site warmth — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Arm feels hot to the touch around the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-14
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-15
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, HeadacheAdult check-in
- 2021-01-17
-
2021-01-18
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-19
Survey response — day 7, dose 2MedDRA: Dyspnoea, Nasal congestion — Feeling: GoodFree text: Nasal congestion, shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Survey response — day 14, dose 2MedDRA: Dyspnoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: For the day after my last check-in I experienced a worsening shortness of breath that has since dissipated.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-02
- 2021-02-09
-
2021-02-16
Survey response — day 35, dose 2MedDRA: Dyspnoea, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Shortness of breath · Healthcare visit (other): Physician- regular office visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-23
- 2021-04-13
- 2021-07-13
-
2021-08-06
Call successfulParticipant prefers to complete VAERS report online
-
2021-10-27
Dose 3 — Pfizer-BioNTech
-
2022-01-14
Survey response — 12 months, dose 2MedDRA: Diarrhoea, Ear pain, Fatigue, Headache, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test, Sneezing — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache, feverish, ear ache, sore throat, fatigue, sneezing, diarrhea. I am waiting for results from a cv-19 testMedDRA releases: 2024-11 · check-in free text available
-
2022-01-27
Survey response — 3 months, dose 3MedDRA: COVID-19, Diarrhoea, SARS-CoV-2 test positive — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Diarrhea - probably because I'm still recovering from cv-19 infection. I tested positive on 1/10/22MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-10-27 | Pfizer-BioNTech | No |
Call center
5 call center cases
2 successful · 3 priority 2/3 (triaged and no follow up)
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Mild Asthma- due to Daily maintenance medications
Healthcare visit (other): Office visit with allergy/ asthma specialist
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Arm feels hot to the touch around the injection site
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Shortness of breath
Release 2 — day 7, dose 2
Systemic reaction (other): Nasal congestion, shortness of breath
Release 2 — day 14, dose 2
Symptoms: For the day after my last check-in I experienced a worsening shortness of breath that has since dissipated.
Release 4 — day 35, dose 2
Release 10 — 12 months, dose 2
Symptoms: Headache, feverish, ear ache, sore throat, fatigue, sneezing, diarrhea. I am waiting for results from a cv-19 test
Release 11 — 3 months, dose 3
Symptoms: Diarrhea - probably because I'm still recovering from cv-19 infection. I tested positive on 1/10/22
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Specialist consultation | ○ | ○ | ○ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Ear pain | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ○ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release